Japan· JP-6134407A2101
ゲンタマイシン硫酸塩
A gentamicin product containing ゲンタマイシン硫酸塩, registered in Japan by 日医工, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Gentamicin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB03 (gentamicin), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 8 of them publish a price we can compare per daily dose
Gentamicin · ATC J01GB03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gentamicin costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gentamicin · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$578.87
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ゲンタマイシン硫酸塩
- Manufacturer
- 日医工
- Country
- Japan (JP)
- ATC code
- J01GB03
- ATC class
- Gentamicin
- Defined daily dose
- 0.24 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
338 interactions on record for gentamicin.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gentamicin · interactions on record
338 records
- 51 severe
- 126 moderate
- 4 minor
- 157 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01GB03
Gentamicin, as other registers publish it.
- United KingdomCidomycin 80mg/2ml solution for injection ampoulesAdvanz Pharma
- United KingdomCidomycin 80mg/2ml solution for injection vialsAdvanz Pharma
- United KingdomCidomycin Intrathecal 5mg/1ml solution for injection ampoulesAventis Pharma
- United KingdomCidomycin Paediatric 20mg/2ml solution for injection vialsBeacon Pharmaceuticals Ltd
- BelgiumDuracoll 130 mgSERB
- BelgiumDuracoll 32.5 mgSERB
- FinlandG-MycinOrion Corporation Orion Pharma
- FinlandG-MycinOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7baf7d2-62fc-4d7b-86eb-e8423e7ca134 GET /v1/drugs/e7baf7d2-62fc-4d7b-86eb-e8423e7ca134?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "40mg1管",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6134407A2101",
"category": "注射薬",
"price_yen": 291,
"generic_name": "ゲンタマイシン硫酸塩",
"product_name_jp": null,
"therapeutic_class": "6134",
"transitional_expiry": null
}See everything about gentamicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.